Schuh AC - Search Results

1

A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis.

Shalaby F, Ho J, Stanford WL, Fischer KD, Schuh AC, Schwartz L, Bernstein A, Rossant J. Shalaby F, et al. Among authors: schuh ac. Cell. 1997 Jun 13;89(6):981-90. doi: 10.1016/s0092-8674(00)80283-4. Cell. 1997. PMID: 9200616 Free article.

2

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. Shalaby F, et al. Among authors: schuh ac. Nature. 1995 Jul 6;376(6535):62-6. doi: 10.1038/376062a0. Nature. 1995. PMID: 7596435

3

Two distinct target cells for v-jun mediated wound tumorigenesis.

Shalaby F, Schuh AC, Breitman ML. Shalaby F, et al. Among authors: schuh ac. Oncogene. 1994 Sep;9(9):2579-88. Oncogene. 1994. PMID: 8058321

4

Altered growth and spontaneous transformation of cells cultured from v-jun transgenic mice recapitulate wound-induced multistage tumorigenesis.

Schuh AC, Theodorescu D, Shalaby F, Breitman ML. Schuh AC, et al. Cell Growth Differ. 1993 Mar;4(3):177-84. Cell Growth Differ. 1993. PMID: 8466856

5

In vitro hematopoietic and endothelial potential of flk-1(-/-) embryonic stem cells and embryos.

Schuh AC, Faloon P, Hu QL, Bhimani M, Choi K. Schuh AC, et al. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2159-64. doi: 10.1073/pnas.96.5.2159. Proc Natl Acad Sci U S A. 1999. PMID: 10051611 Free PMC article.

6

Early embryonic expression of murine coagulation system components.

Ong K, Horsfall W, Conway EM, Schuh AC. Ong K, et al. Among authors: schuh ac. Thromb Haemost. 2000 Dec;84(6):1023-30. Thromb Haemost. 2000. PMID: 11154109

7

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy.

Spiegel JY, McNamara C, Kennedy JA, Panzarella T, Arruda A, Stockley T, Sukhai M, Thomas M, Bartoszko J, Ho J, Siddiq N, Maze D, Schimmer A, Schuh A, Sibai H, Yee K, Claudio J, Devlin R, Minden MD, Kamel-Reid S, Gupta V. Spiegel JY, et al. Blood Adv. 2017 Sep 8;1(20):1729-1738. doi: 10.1182/bloodadvances.2017009530. eCollection 2017 Sep 12. Blood Adv. 2017. PMID: 29296819 Free PMC article.

8

Assessment of the downstream portion of the mitochondrial pathway of caspase activation in patients with acute myeloid leukemia.

Gronda M, Brandwein J, Minden MD, Pond GR, Schuh AC, Wells RA, Messner H, Chun K, Schimmer AD. Gronda M, et al. Among authors: schuh ac. Apoptosis. 2005 Dec;10(6):1285-94. doi: 10.1007/s10495-005-2764-4. Apoptosis. 2005. PMID: 16215669

9

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes.

McNamara CJ, Panzarella T, Kennedy JA, Arruda A, Claudio JO, Daher-Reyes G, Ho J, Siddiq N, Devlin R, Tsui H, Su J, Stockley T, Sukhai M, Kanwar N, Chan S, Maze D, Schimmer A, Schuh A, Sibai H, Viswabandya A, Yee K, Minden MD, Kamel-Reid S, Gupta V. McNamara CJ, et al. Blood Adv. 2018 Oct 23;2(20):2658-2671. doi: 10.1182/bloodadvances.2018021469. Blood Adv. 2018. PMID: 30327374 Free PMC article.

10

Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice.

Schuh AC, Keating SJ, Monteclaro FS, Vogt PK, Breitman ML. Schuh AC, et al. Nature. 1990 Aug 23;346(6286):756-60. doi: 10.1038/346756a0. Nature. 1990. PMID: 2167455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters